Akebia Therapeutics financial statements

아케비아 테라퓨틱스NASDAQ:AKBA · Nasdaq · Healthcare · sector #17
$0.8785-3.51%
2026-10-06 close

Akebia Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $160M. 2024 operating profit was −$51M.

Reported results

Akebia Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q